Hormonal Contraceptive Use May Delay Return of Fecundability
WEDNESDAY, Nov. 18, 2020 -- Pregravid use of some hormonal contraceptives is associated with delays in return of fertility, according to a study published online Nov. 11 in The BMJ.
Jennifer J. Yland, from the Boston University School of Public Health, and colleagues examined the correlation between pregravid use of a variety of contraceptive methods and subsequent fecundability in a prospective cohort study. Data were included for 17,954 women who had tried to conceive for up to six menstrual cycles at study entry. Contraceptive histories and personal, medical, and lifestyle characteristics were reported at baseline.
The researchers found that about 38, 13, and 31 percent of participants had recently used oral contraceptives, long-acting reversible contraceptive methods, and barrier methods, respectively. Compared with users of barrier methods, women who had recently stopped using oral contraceptives, the contraceptive ring, and some long-acting reversible contraceptive methods experienced short-term delays in return of fertility. There was a correlation seen for use of injectable contraceptives with decreased fecundability compared with barrier method use (fecundability ratio, 0.65). The longest delay in return of normal fertility was seen for users of injectable contraceptives, followed by users of patch contraceptives, users of oral and ring contraceptives, and users of hormonal and copper intrauterine devices and implant contraceptives (five to eight, four, three, and two cycles, respectively).
"Our results, although imprecise, indicate little or no lasting effect of long-term use of these methods on fecundability," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
© 2020 HealthDay. All rights reserved.
Posted: November 2020
Read this next
TUESDAY, Dec. 1, 2020 -- A strawberry-flavored version of the first-line HIV medication dolutegravir will soon be available for infants. The medication will come in a tablet that...
MONDAY, Nov. 30, 2020 -- Pregnancies in women with psoriasis have an increased risk for adverse outcomes, including preeclampsia and stillbirth, according to a study published...
MONDAY, Nov. 30, 2020 -- Women treated with assisted reproductive technology (ART) do not have an increased risk for ovarian cancer compared with subfertile women not receiving...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.